EQRx, Inc. (EQRX): Price and Financial Metrics
GET POWR RATINGS... FREE!
EQRX Stock Price Chart Interactive Chart >
EQRX Price/Volume Stats
| Current price | $2.40 | 52-week high | $6.05 |
| Prev. close | $2.50 | 52-week low | $1.87 |
| Day low | $2.40 | Volume | 1,622,611 |
| Day high | $2.52 | Avg. volume | 3,504,096 |
| 50-day MA | $2.64 | Dividend yield | N/A |
| 200-day MA | $4.25 | Market Cap | 1.17B |
EQRx, Inc. (EQRX) Company Bio
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EGFR-mutated non-small cell lung cancer (NSCLC); and Sugemalimab, an anti-programmed death-ligand 1 antibody for the treatment of Stage III and Stage IV NSCLC. Its other programs in pipeline include clinical and pre-clinical stage assets, which comprise Lerociclib, a small molecule cyclin-dependent kinase 4/6 inhibitor, which is in Phase I clinical trials in patients with metastatic breast cancer; EQ176, an anti-programmed death-1 antibody that is in Phase III trials for the treatment of patients with primary liver cancer; and EQ121, a selective janus kinase-1 inhibitor that is in various Phase I trials. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Latest EQRX News From Around the Web
Below are the latest news stories about EQRX INC that investors may wish to consider to help them evaluate EQRX as an investment opportunity.
EQRx Inc. (NASDAQ: EQRX) Stock: More Upside Ahead?In the last trading session, 1.55 million EQRx Inc. (NASDAQ:EQRX) shares changed hands as the company’s beta touched 0. With the company’s per share price at $2.43 changed hands at $0.09 or 3.85% during last session, the market valuation stood at $1.14B. EQRX’s last price was a discount, traded about -148.97% off its 52-week high … EQRx Inc. (NASDAQ: EQRX) Stock: More Upside Ahead? Read More » |
EQRx Inc. (NASDAQ:EQRX) Up Almost 4.95% In One Month, Looking Good For The Long TermIn last trading session, EQRx Inc. (NASDAQ:EQRX) saw 4.27 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $2.33 trading at -$0.13 or -5.28% at ring of the bell on the day assigns it a market valuation of $1.05B. That closing price of EQRX’s stock is at … EQRx Inc. (NASDAQ:EQRX) Up Almost 4.95% In One Month, Looking Good For The Long Term Read More » |
EQRx promised to deliver cutting-edge drugs at half the cost of rivals. A cofounder shares why the once buzzy biotech is walking away from that missionEQRx''s Alexis Borisy told Insider that regulatory delays, caused by reliance on China-based data, had changed EQRx''s pricing strategy. |
EQRx Inc. (NASDAQ: EQRX) Stock Has Dropped -1.75% Over The Month – Is There Room For Growth?EQRx Inc. (NASDAQ:EQRX)’s traded shares stood at 5.42 million during the last session. At the close of trading, the stock’s price was $2.80, to imply an increase of 0.36% or $0.01 in intraday trading. The EQRX share’s 52-week high remains $7.69, putting it -174.64% down since that peak but still an impressive 33.21% since price … EQRx Inc. (NASDAQ: EQRX) Stock Has Dropped -1.75% Over The Month – Is There Room For Growth? Read More » |
Let’s Jump Into The EQRx Inc. (NASDAQ: EQRX) Stock ForecastIn the last trading session, 2.47 million EQRx Inc. (NASDAQ:EQRX) shares changed hands as the company’s beta touched 0. With the company’s per share price at $2.71 changed hands at -$0.12 or -4.24% during last session, the market valuation stood at $1.28B. EQRX’s last price was a discount, traded about -183.76% off its 52-week high … Let’s Jump Into The EQRx Inc. (NASDAQ: EQRX) Stock Forecast Read More » |
EQRX Price Returns
| 1-mo | -11.44% |
| 3-mo | -38.30% |
| 6-mo | -50.21% |
| 1-year | -37.50% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -2.44% |
| 2022 | -63.93% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...